Chiesi Farmaceutici - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsChiesi Farmaceutici

Chiesi Farmaceutici

Chiesi Farmaceutici S.p.A. is an Italian family controlled global pharmaceutical company based in Parma, Emilia-Romagna. Chiesi has 30 affiliates in the world, nearly 6,389 total employees and provides medicines to patients in 90 nations. Chiesi currently has revenues of 2.229 billion euros. According to 2020 official data from the European Patent Office (EPO), Chiesi Group, with 38 patents filed, is confirmed the first Italian Pharmaceutical Company and fourth among Italian Companies across all sectors for filing the highest number of patents.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Bethkis	Tobramycin	2012-10-12	2024-2030	Respiratory tract infections , Cystic fibrosis , Urinary tract infections , Bacterial infections , Intraabdominal infections , Pseudomonas infections , Infectious skin diseases , Bacterial eye infections , Staphylococcal infections , Central nervous system infections , Infectious bone diseases , Leukemia , Septic shock , Ulcerative colitis , Ankylosing spondylitis , Vomiting , Nausea , Sarcoidosis , Thrombocytopenic purpura idiopathic , Pulmonary tuberculosis , Mycosis fungoides , Systemic lupus erythematosus , Rheumatic diseases , Bursitis , Keratitis , Allergic rhinitis perennial , Thyroiditis , Iritis , Hypercalcemia , Brain edema , Pemphigus , Addison disease , Collagen diseases , Dermatitis herpetiformis , Rosacea , Inflammation , Edema , Bacterial conjunctivitis , Allergic conjunctivitis , Viral conjunctivitis , Conjunctivitis
Cardene	Nicardipine	1988-12-21	2027	Hypertension , Stable angina , Variant angina pectoris
Cleviprex	Clevidipine	2008-08-01	2031	Hypertension
Curosurf	Poractant alfa	1999-11-18		Newborn respiratory distress syndrome
Envarsus	Tacrolimus	2014-07-18	2024-2028	Atopic dermatitis, Kidney transplantation, Graft vs host disease, Liver transplantation, Graft rejection
Ferriprox	Deferiprone	2011-10-14	2029-2038	Beta-thalassemia, Iron overload
Kengreal	Cangrelor	2015-06-22	2029-2035	Acute coronary syndrome, Vascular surgical procedures
Kengrexal	Cangrelor	2015-03-23	2029-2035	Acute coronary syndrome, Vascular surgical procedures
Lamzede	Velmanase alfa	2023-02-16		Alpha-mannosidosis

1

2

3

>

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

geographic atrophy

,

,

drug interactions

,

,

macular degeneration

,

lung transplantation

,

bone marrow transplantation

,

,

focal segmental glomerulosclerosis

,

iga glomerulonephritis

,

,

,

type 1 diabetes mellitus

,

vulvar lichen sclerosus

,

lichen sclerosus et atrophicus

,

transplantation

,

myasthenia gravis

,

,

transplantation immunology

,

host vs graft reaction

,

dermatomyositis

,

,

interstitial lung diseases

,

,

muscle weakness

,

ulcerative colitis

,

,

,

keratoconjunctivitis

,

,

allergic conjunctivitis

,

,

,

,

organ transplantation

,

kidney transplantation

,

liver transplantation

,

,

atopic dermatitis

,

,

rheumatoid arthritis

,

,

heart transplantation

,

chronic kidney failure

,

kidney diseases

,

lupus nephritis

,

,

graft rejection

,

immunosuppression therapy

,

graft vs host disease

,

renal insufficiency

,

pancreas transplantation

,

,

,

,

medication adherence

,

chronic renal insufficiency

,

nephrotic syndrome

,

,

,

lipoid nephrosis

,

allergic contact dermatitis

,

contact dermatitis

,

prostatic neoplasms

,

erectile dysfunction

,

delayed graft function

,

polyomavirus infections

,

cardiovascular diseases

,

retinal diseases

,

dried blood spot testing

,

diabetes mellitus

,

,

postoperative complications

,

,

,

,

,

keratoconjunctivitis

,

meibomian gland dysfunction

,

,

alpha-mannosidosis

,

mannosidase deficiency diseases

respiratory aspiration

,

,

disease progression

,

chronic obstructive pulmonary disease

,

obstructive lung diseases

,

,

myocardial infarction

,

,

st elevation myocardial infarction

,

percutaneous coronary intervention

,

acute coronary syndrome

,

,

coronary artery disease

Glycopyrronium bromide

healthy volunteers/patients

,

respiratory aspiration

,

,

obstructive lung diseases

,

,

disease progression

,

chronic obstructive pulmonary disease

,

beta-thalassemia

,

,

,

nerve degeneration

,

pantothenate kinase-associated neurodegeneration

,

catheter obstruction

respiratory aspiration

,

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

tissue adhesions

,

,

disease progression

,

,

,

,

,

,

,

chronic obstructive pulmonary disease

,

obstructive lung diseases

,

,

healthy volunteers/patients

,

respiratory aspiration

,

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

tissue adhesions

,

,

disease progression

,

,

,

chronic obstructive pulmonary disease

,

obstructive lung diseases

,

,

Formoterol fumarate dihydrate

,

Elapegademase-lvlr

severe combined immunodeficiency

congenital heart defects

,

,

hypoplastic left heart syndrome

,

acute lung injury

,

hyaline membrane disease

,

respiratory distress syndrome

,

newborn respiratory distress syndrome

,

,

premature birth

,

bronchopulmonary dysplasia

,

premature infant diseases

,

Pegunigalsidase alfa

severe combined immunodeficiency

1

2

3

4

5

>

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use